BRPI0719826A2 - Composição sólida termoestável, e, processo de preparar uma composição farmacêutica sólida. - Google Patents

Composição sólida termoestável, e, processo de preparar uma composição farmacêutica sólida.

Info

Publication number
BRPI0719826A2
BRPI0719826A2 BRPI0719826-4A2A BRPI0719826A BRPI0719826A2 BR PI0719826 A2 BRPI0719826 A2 BR PI0719826A2 BR PI0719826 A BRPI0719826 A BR PI0719826A BR PI0719826 A2 BRPI0719826 A2 BR PI0719826A2
Authority
BR
Brazil
Prior art keywords
solid
composition
preparing
thermostable
pharmaceutical composition
Prior art date
Application number
BRPI0719826-4A2A
Other languages
English (en)
Inventor
Jan P Moeschwitzer
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Priority claimed from PCT/EP2007/061194 external-priority patent/WO2008046905A1/en
Publication of BRPI0719826A2 publication Critical patent/BRPI0719826A2/pt
Publication of BRPI0719826A8 publication Critical patent/BRPI0719826A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI0719826A 2006-10-20 2007-10-19 Composição sólida termoestável, e, processo de preparar uma composição farmacêutica sólida BRPI0719826A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06122648 2006-10-20
PCT/EP2007/061194 WO2008046905A1 (en) 2006-10-20 2007-10-19 Micellar nanoparticles of chemical substances

Publications (2)

Publication Number Publication Date
BRPI0719826A2 true BRPI0719826A2 (pt) 2014-05-06
BRPI0719826A8 BRPI0719826A8 (pt) 2017-04-04

Family

ID=37671256

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0719826A BRPI0719826A8 (pt) 2006-10-20 2007-10-19 Composição sólida termoestável, e, processo de preparar uma composição farmacêutica sólida

Country Status (8)

Country Link
CN (2) CN101686946A (pt)
AR (1) AR063330A1 (pt)
BR (1) BRPI0719826A8 (pt)
HK (1) HK1199829A1 (pt)
MX (1) MX2009004124A (pt)
SA (1) SA07280548B1 (pt)
TW (1) TWI392507B (pt)
UA (1) UA97496C2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI661841B (zh) * 2017-04-19 2019-06-11 三凡生技研發股份有限公司 用於分散疏水性植物萃取物之載劑
EP3424493A1 (en) * 2017-07-07 2019-01-09 SolMic Research GmbH Stable cannabinoid compositions
CN110302155B (zh) 2019-07-31 2021-09-21 江南大学 一种黄原胶共聚物纳米胶束的制备方法及其应用
CN112915121A (zh) * 2019-12-06 2021-06-08 汉义生物科技（北京）有限公司 一种大麻素纳米胶束制剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9700866B2 (en) * 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
DE60216287T2 (de) * 2001-07-13 2007-05-31 Nanocarrier Co., Ltd. Lyophilisierende zusammensetzung von wirkstoff-verkapselnder polymer-mizelle und verfahren zu ihrer herstellung
IL153277A0 (en) * 2002-12-04 2003-07-06 Pharmos Corp High enantiomeric purity dexanabinol for pharmaceutical compositions
US20060003976A1 (en) * 2004-06-04 2006-01-05 Yuehua Zhang Cholesterol/bile acid/bile acid derivative-modified therapeutic drug compounds

Also Published As

Publication number Publication date
TWI392507B (zh) 2013-04-11
HK1199829A1 (en) 2015-07-24
TW200824711A (en) 2008-06-16
SA07280548B1 (ar) 2011-10-08
CN101686946A (zh) 2010-03-31
AR063330A1 (es) 2009-01-21
BRPI0719826A8 (pt) 2017-04-04
UA97496C2 (ru) 2012-02-27
MX2009004124A (es) 2009-07-22
CN104188926A (zh) 2014-12-10

Similar Documents

Publication Publication Date Title
BRPI0718339A2 (pt) Composto, composição, composição farmacêutica e processo de fabricação de tanato de rasagilina
BRPI0820139A2 (pt) Composição antiperspirante ativa, e, processo de obtenção de uma composição antiperspirante ativa
BRPI0811712A2 (pt) "composto, processo de preparação de um composto e composição farmacéutica".
BRPI0818533A2 (pt) composto, composição farmacêutica, e, processo para a preparação de um composto
BRPI0817706A2 (pt) Processo de preparação de uma composição de concreto úmida, composição de concreto úmida e objeto de concreto endurecido.
BRPI0717695A2 (pt) "composição, uso de uma compsição e processo de preparação de uma composição"
BRPI0821445A2 (pt) Folha, processo de fabricação de uma folha, e, artigo
BRPI0717753A2 (pt) Método de tratamento ou redução do risco de uma doença causada por protozoários, e, composição.
BRPI0820997A2 (pt) Comprimidos de desintegração oral compreendendo difenidramina.
BRPI0809573A2 (pt) composição, e, método
BRPI0716703A2 (pt) "composiÇço, fluidos funcionais e processo de preparaÇço de uma composiÇço"
BRPI0719272A2 (pt) Composição de enzima, e, método para preparar uma composição de enzima.
BRPI0821801A2 (pt) Zeólito e processo de preparação de um zeólito.
EP2041323A4 (en) VIROSOMES, METHODS OF PREPARATION AND IMMUNOGENIC COMPOSITIONS
BRPI0815922A2 (pt) Artigo, composição, e, método.
BRPI0820644A2 (pt) método de preparação de uma composição, e, composição
BRPI0814167A2 (pt) Composição, e, método
BRPI0925037A2 (pt) Composição contendo piceatanol e método de produzir a composição contendo piceatanol.
BRPI0814448A2 (pt) processo de produção de trazodona e cloridrato de trazodona, trazodona e cloridrato de trazodona, e, composição farmacêutica
BRPI1014436A2 (pt) composto, processo de preparação de um composto, intermediário, composições farmacêuticas, e, utilização de um composto.
BRPI0718565A2 (pt) Forma de dosagem sólida, e, método de produção de uma forma de dosagem sólida.
BRPI0718999A2 (pt) Pirazois substituídos, composições que os contêm, processo de produção e utilização
BRPI0810560A2 (pt) Composição de bebida, processo para produzir uma composição de bebida, e, uso de uma composição de bebida.
BRPI0719706A2 (pt) Processo para a preparação do 1,3-propanodiol.
EP2026842A4 (en) N-TERMINAL-MODIFIED PEG-TRAIL, METHOD OF PREPARATION AND USE

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: ABBOTT HEALTHCARE PRODUCTS B.V. (NL)

B25A Requested transfer of rights approved

Owner name: ABBVIE B.V (NL)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 13A ANUIDADE.

B07F Notification of approval that there is no relation to art. 229 of lpi (pipeline patents) [chapter 7.6 patent gazette]
B11R Patent application dismissed according to article 229 of the patent law [chapter 11.18 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2599 DE 27-10-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.